Biomarkers of neurodegeneration in the cerebrospinal fluid (CSF), such as tau proteins, neurofilament light chain protein (NfL), and glial fibrillary acidic protein (GFAp), are increased in COVID-19 patients and associated both with neurological symptoms and disease severity [53,54,55,56,57]. The gene discussed is GFAP; the disease is COVID-19.